EP Patent
EP2250148B1 — Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
Assigned to XenoPort Inc · Expires 2016-08-17 · 10y expired
What this patent protects
Patent listed against Horizant.
Drugs covered by this patent
- Horizant (GABAPENTIN ENACARBIL) · Azurity
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.